7Baggers
 Chad Robins Sells 89,265 Shares of Adaptive Biotechnologies Corp  GuruFocus Thu, 13 Nov 2025 02:30:05 GMT
 Adaptive Biotechnologies CEO Robins sells $1.3m in shares By Investing.com  Investing.com Nigeria Thu, 13 Nov 2025 01:28:21 GMT
 Adaptive Biotechnologies Executives Sell Shares Under Trading Plan  TradingView Thu, 13 Nov 2025 00:40:00 GMT
 (adpt) movement within algorithmic entry frameworks  news.stocktradersdaily.com Wed, 12 Nov 2025 13:06:02 GMT
 Adaptive Biotechnologies (ADPT): Morgan Stanley Raises Price Tar  GuruFocus Tue, 11 Nov 2025 17:05:11 GMT
 adaptive biotechnologies reports strong q3 2025 growth  MSN Mon, 10 Nov 2025 02:55:37 GMT
 Adaptive Biotechnologies’ Earnings Call Highlights Growth and Challenges  The Globe and Mail Fri, 07 Nov 2025 08:00:00 GMT
 adaptive biotechnologies: q3 earnings snapshot  ctinsider.com Thu, 06 Nov 2025 11:25:54 GMT
 Why Adaptive Biotechnologies Shares Are on the Rise  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 adaptive biotechnologies earnings beat by $0.23, revenue topped estimates  Investing.com Australia Thu, 06 Nov 2025 08:00:00 GMT
 adaptive biotechnologies q3 2025 earnings call transcript  MarketBeat Thu, 06 Nov 2025 05:55:49 GMT
 adaptive biotechnologies reports strong q3 2025 growth  TipRanks Thu, 06 Nov 2025 05:38:57 GMT
 adaptive biotechnologies reports q3 eps 6c, consensus (14c)  TipRanks Wed, 05 Nov 2025 22:30:10 GMT
 Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results  GlobeNewswire Wed, 05 Nov 2025 21:05:00 GMT
 Adaptive Biotechnologies: Q3 Earnings Snapshot  New Haven Register Wed, 05 Nov 2025 08:00:00 GMT
 Adaptive Biotechnologies Reports Strong Q3 2025 Growth  TipRanks Wed, 05 Nov 2025 08:00:00 GMT
 adaptive biotechnologies earnings notes  Trefis Tue, 04 Nov 2025 08:00:00 GMT

Adaptive Biotechnologies Corporation
(NASDAQ:ADPT) 

ADPT stock logo

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer translational research questions, as well as to discover new progno...

Founded: 2009
IPO Price: $20 (Jun 27, 2019)
Full Time Employees: 453
CEO: Chad Robins  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends